Monthly Archives: June 2015

The stealth properties of PEG-coated nanoparticles are dependent on the PEG grafting densities

The Lai lab at UNC Chapel Hill published an article in Molecular Pharmaceiuticals – Evading Immune Cell Uptake and Clearance Requires PEG Grafting at Densities Substantially Exceeding the Minimum for Brush Conformation. Mol. Pharmaceutics, 2014, 11 (4), pp 1250–1258, DOI: … Continue reading

Posted in Blogs | 1 Comment

How Pegylated Drugs are Aiding Rheumatology

PEG Therapy Since PEG molecules bind to amino acids to target proteins, they are now being used in the Rheumatology field. For patients with Rheumatoid Arthritis who do not respond to standard treatment, the use of TNF-a inhibitors have been … Continue reading

Posted in Blogs | Tagged | Leave a comment

FDA approved PEGylated drug

Originally posted on Creative PEGWorks:
To date, eleven PEGylated proteins, antibody fragments, oligonucleotides, and small molecules have been approved by FDA are on the market, including PEGylated bovine adenosine deaminase: pegademase bovine (Adagen); and PEGylated l-asparaginase: pegaspargase (Oncaspar); PEGylated products…

Posted in Blogs | Leave a comment